back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-09-06 12:02 Tx date 2019-09-06 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
37 - Stock split or consolidation
|
-214,030 vol |
209 | |
| Filed 2019-09-04 16:58 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-31,950
-22,500 vol $1.42 each |
214,239 | |
| Filed 2019-09-04 16:57 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-12,168
-31,200 vol $0.39 each |
236,739 | |
| Filed 2019-06-22 12:47 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
57 - Exercise of rights
|
$-454.9816
-29,933 vol $0.0152 each |
0 | |
| Filed 2019-06-22 12:34 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,099
+598,660 vol $0.0152 each |
913,101 | |
| Filed 2019-06-22 12:29 Tx date 2019-05-24 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
56 - Grant of rights
|
$454.98
+29,933 vol $0.0152 each |
29,933 | |
| Filed 2019-06-22 12:28 Tx date 2016-08-10 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-22 12:24 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-122,000
-50,000 vol $2.44 each |
9,375,000 | |
| Filed 2019-06-22 12:23 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-105,000
-35,000 vol $3.00 each |
9,425,000 | |
| Filed 2019-06-22 12:22 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-93,150
-45,000 vol $2.07 each |
9,460,000 | |
| Filed 2019-06-22 12:21 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-90,090
-117,000 vol $0.77 each |
9,505,000 | |
| Filed 2019-06-22 12:20 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$84,375
+3,125,000 vol $0.027 each |
9,622,000 | |
| Filed 2019-06-22 12:19 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$168,750
+6,250,000 vol $0.027 each |
6,497,000 | |
| Filed 2019-06-10 16:45 Tx date 2019-05-27 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-52,800
-48,000 vol $1.10 each |
247,000 | |
| Filed 2019-05-31 15:26 Tx date 2019-05-30 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-85,782
-295,800 vol $0.29 each |
267,939 | |
| Filed 2019-02-06 Tx date 2019-02-01 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,782
+295,800 vol $0.29 each |
563,739 | |
| Filed 2019-02-06 Tx date 2018-12-31 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
58 - Expiration of rights
|
$-80,073
-27,900 vol $2.87 each |
267,939 | |
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
||
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$48,672
+124,800 vol $0.39 each |
295,839 | |
| Filed 2018-12-17 Tx date 2018-12-14 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-20,000
-50,000 vol $0.40 each |
295,000 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
264,639 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$90,090
+117,000 vol $0.77 each |
345,000 | |
| Filed 2018-03-28 Tx date 2018-03-22 |
$PLI
Prometic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
58 - Expiration of rights
|
$-41,484.60
-24,260 vol $1.71 each |
171,039 | |
| Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$117,150
+82,500 vol $1.42 each |
209,299 | |
| Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,200
+60,000 vol $1.42 each |
||
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,620.9094
-4,986 vol $1.33 each |
314,441 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,550
+5,000 vol $1.71 each |
313,197 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,678.283
-2,770 vol $1.33 each |
310,427 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$25,830
+9,000 vol $2.87 each |
319,427 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-8,550
-5,000 vol $1.71 each |
181,799 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-25,830
-9,000 vol $2.87 each |
172,799 | |
| Filed 2017-11-28 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,200
+60,000 vol $1.42 each |
186,799 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-205,733.33
-98,437 vol $2.09 each |
126,799 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,940
+14,000 vol $1.71 each |
313,699 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,773.9467
-7,803 vol $1.51 each |
305,896 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,924
+5,200 vol $2.87 each |
311,096 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,374.3011
-2,899 vol $1.51 each |
308,197 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$205,733
+98,437 vol $2.09 each |
406,634 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-148,531.5893
-98,437 vol $1.51 each |
308,197 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-78,412.50
-63,750 vol $1.23 each |
244,436 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-23,940
-14,000 vol $1.71 each |
230,436 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-14,924
-5,200 vol $2.87 each |
225,236 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$78,412
+63,750 vol $1.23 each |
335,216 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,591.6013
-35,517 vol $1.51 each |
299,699 | |
| Filed 2017-08-29 Tx date 2017-08-25 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,000
+50,000 vol $0.12 each |
271,466 | |
| Filed 2017-08-29 Tx date 2017-08-25 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,000
-50,000 vol $0.12 each |
228,000 | |
| Filed 2017-07-24 Tx date 2017-01-16 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-10,184 vol |
||
| Filed 2017-07-24 Tx date 2017-01-16 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-10,184 vol |
224,012 | |
| Filed 2017-07-10 Tx date 2017-01-16 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: CELI (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+2,546 vol |
29,933 | |
| Filed 2017-07-10 Tx date 2017-01-16 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-10,184 vol |
224,012 | |
| Filed 2017-07-10 Tx date 2017-01-16 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-2,546 vol |
221,466 | |
| Filed 2017-05-23 Tx date 2017-05-18 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$93,150
+45,000 vol $2.07 each |
278,000 | |
| Filed 2017-04-13 Tx date 2017-04-11 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$205,733
+98,437 vol $2.09 each |
308,186 | |
| Filed 2017-03-28 Tx date 2017-03-23 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
58 - Expiration of rights
|
$-267,525
-217,500 vol $1.23 each |
209,749 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$27,253
+15,938 vol $1.71 each |
243,867 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,368.93
-9,671 vol $2.83 each |
234,196 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-27,253.98
-15,938 vol $1.71 each |
427,249 | |
| Filed 2016-10-16 Tx date 2016-10-11 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$172,200
+60,000 vol $2.87 each |
443,187 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,840
+4,000 vol $1.71 each |
230,152 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,202.17
-2,223 vol $2.79 each |
227,929 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-6,840
-4,000 vol $1.71 each |
383,187 | |
| Filed 2016-08-11 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
233,000 | ||
| Filed 2016-08-11 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
226,152 | ||
| Filed 2016-08-11 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: CELI (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
27,387 | ||
| Filed 2016-08-11 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: REER (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
23,838 | ||
| Filed 2016-08-11 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Gagnon, Lyne
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
387,187 |